Skip to main content
Phreesia, Inc. (PHR)
NYSE: PHR · IEX Real-Time Price · USD
20.61
+0.15 (0.73%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Phreesia Revenue

In the fiscal year ending January 31, 2024, Phreesia had annual revenue of $356.30M with 26.84% growth. Revenue in the quarter ending January 31, 2024 was $95.01M with 24.05% year-over-year growth.

Revenue (ttm)
$356.30M
Revenue Growth
+26.84%
P/S Ratio
3.26
Revenue / Employee
$247,774
Employees
1,438
Market Cap
1.16B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jan 31, 2024356.30M75.39M26.84%
Jan 31, 2023280.91M67.68M31.74%
Jan 31, 2022213.23M64.56M43.42%
Jan 31, 2021148.68M23.89M19.15%
Jan 31, 2020124.78M24.90M24.92%
Jan 31, 201999.89M20.06M25.12%
Jan 31, 201879.83M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Pacira BioSciences 674.98M
Collegium Pharmaceutical 566.77M
Ironwood Pharmaceuticals 442.74M
MannKind 198.96M
Mirum Pharmaceuticals 186.37M
Deciphera Pharmaceuticals 163.36M
4D Molecular Therapeutics 20.72M
Tarsus Pharmaceuticals 17.45M
Revenue Rankings

PHR News

More News